Polyoma-(PY) and Papillomavirus (PV) virions have remarkable structural equivalence although no discernable sequence similarities among the capsid proteins can be detected. Their similarities include the overall surface organization, the presence of 72 capsomeres composed of five molecules of the major capsid proteins, VP1 and L1, respectively, the structure of the core segment of capsomeres with classical antiparallel "jelly roll" β strands as the major feature, and the linkage of neighboring capsomeres by invading C-terminal arms. Differences include the size of surface exposed loops that contain the dominant neutralizing epitopes, the details of the intercapsomeric interactions, and the presence of 2 or 1 minor capsid proteins, respectively. These differences may affect the dramatic differences observed in receptor binding and internalization pathways utilized by these viruses, but as detailed later even structural differences cannot completely explain receptor and pathway usage. In recent years, technical advances aiding the study of entry processes have allowed the identification of novel endocytic compartments and an appreciation of the links between endocytic pathways that were previously thought to be completely separable. This review is intended to highlight recent advances in our understanding of virus receptor interactions and their consequences for endocytosis and intracellular trafficking.
The outer shell of Polyomavirus (PY) virions is composed of 360 molecules of the major capsid protein VP1. They are organized into 72 capsomeres, each comprised of a pentameric VP1 assembly, centered on the vertices of a T = 7 icosahedral lattice. Twelve and sixty capsomeres are pentavalent and hexavalent, i.e. they have five and six nearest neighbors, respectively. The core of the capsomeres is mainly composed of an antiparallel β-sandwich to which eight β strands labeled B through I contribute (Liddington et al., 1991; . They run roughly parallel to the 5-fold axis and are connected by small loops. The BC, DE, FG, and HI loops face outwards and contain the major neutralizing epitopes. The five VP1 molecules within a capsomere are intimately associated, even displaying an interlock of their secondary structures. The overall structure of the β-sandwich is identical in all capsomeres.
Neighboring capsomeres are linked by invading C-terminal arms, with each capsomere donating 5 arms and likewise receiving 5 arms from 5 neighboring capsomeres. These interactions are stabilized by Ca 2+ ions and disulfide bonds. The interactions by the sequence elements inserting into the neighboring capsomeres (C insert; residues 315 to 344 in SV40 VP1) are the same for all VP1 molecules. The A β-strand and A α-helix of the receiving VP1 molecules provide a clamp which locks the J strand (residues 330 to 336) of the C insert into place. This interaction is further stabilized by residues 337 to 344, which wrap around the N-terminal arm and end at the Ca 2+ -binding site (Li et al., 2003) . The C-terminal arm also contains the C helix and the C loop, which are the most variable parts and differ in the three distinct kinds of capsomere-capsomere interactions. Three-fold clusters link one VP1 molecule from pentavalent capsomeres to two VP1 molecules donated by two neighboring hexavalent capsomeres such that C-terminal arms are exchanged in a cyclical fashion. Two different 2-fold clusters each contain two hexavalent capsomeres and are found at the icosahedral 3-fold and 2-fold axis, respectively. In SV40, this configuration brings the highly conserved cysteine residues at position 104 (C104) into close proximity allowing them to engage in disulfide bonds. In the three-fold clusters, one C104 remains reduced and is not involved in disulfide bond formation (Liddington et al., 1991) . Recent evidence suggests that the cysteine residue at position 9 (C9), which was not visible in the X-ray structure, forms C9-C9 disulfide bonds and also contributes to intercapsomeric crosslinks between VP1 molecules (Schelhaas et al., 2007) . Thus, essentially all VP1 molecules in the particle are covalently connected. In murine PY (PyV), such an extended cross-linking is not observed which may have consequences for the specific requirements of viral uncoating during entry (see below). Virology 384 (2009) [400] [401] [402] [403] [404] [405] [406] [407] [408] [409] In addition to VP1, 72 molecules of minor capsid proteins, VP2 and VP3, are present in the viral capsid. VP2 differs from VP3 by an Nterminal extension of 116 residues that carries a myristylation site (Gasparovic et al., 2006; Krauzewicz et al., 1990; Sahli et al., 1993) . A highly conserved C-terminal fragment spanning residues 266 to 302 (VP2 numbering) inserts in a hairpin-like manner into the axial cavity of capsomeres present on the inner capsomere surface. Strong hydrophobic interactions with 3 of the 5 VP1 molecules anchor the VP2/VP3 molecules . Due to high flexibility no structural information could be obtained for other parts of VP2 but it is believed to be completely hidden inside the capsid and thus not accessible, e.g. to antibody binding (Norkin et al., 2002) .
Papillomaviruses
Like the PY capsid, the outer shell of Papillomaviruses (PV) is composed of 360 molecules of the major capsid protein, L1 (Baker et al., 1991) . The structural information for HPV16 was derived from T = 1 capsids composed of only 12 pentamers. The core capsomere is very similar to the PY structure with eight β-strands contributing to the antiparallel β-sandwich (Chen et al., 2000) (Figs. 1A, B) . The BC, DE, FG, and HI surface loops are considerably larger. The larger size of L1 as compared to VP1 explains size differences between the PY and PV capsids (50 nm as compared to 60 nm, respectively). This structural information suggested that the C-terminal arm folds back into the core structure from which it emanates leaving only helix 2, 3 and 4 for pentamer-pentamer interactions via mainly hydrophobic bonds. However, modeling based on the T = 1 small VLP crystal structure information (Chen et al., 2000) and electron cryomicroscopy image reconstruction (Modis et al., 2002) suggests that C-terminal arms invade neighboring capsomeres to form the principal interpentamer contacts similar to PY (Fig. 1C) . This model implies that a flexible hinge composed of residues 403 to 413 (HPV16 L1) bridges the gap between capsomeres and is located at the base of the protein shell. Residues 419 to 429 form a α-helix (h4) that reaches halfway up the wall of the invaded capsomere and brings Cys-428 in close contact with Cys-175 thus allowing disulfide formation (Modis et al., 2002) . Disulfide bond formation between these residues was confirmed by mass spectrometry. In previous reports two groups had independently provided evidence using a mutational approach that these cysteine residues are involved in intercapsomeric disulfide bond formation (Li et al., 1998; Sapp et al., 1998) . The model further suggests that residues 430 to 446 extend around the circumference of the targeted capsomere. Residues 447 to 474 form the J β-strand and h5 helix that insert between two L1 molecules of the invaded capsomere and firmly link capsomeres. Disulfide bond formation is not essential for virion formation but strongly stabilizes virions and renders them resistant to nuclease and protease treatment (Buck et al., 2005; Fligge et al., 2001 ). In this model the majority of the C-terminal arm is surface-exposed, although located within the intercapsomeric cleft, and thus may contribute to the induction of neutralizing antibodies and may provide surfaces for receptor binding. Indeed, binding sites of some neutralizing antibodies have been mapped to the C-terminal arm (Carter et al., 2003) . However, the majority of neutralizing antibodies bind to conformational epitopes to which the surface loops BC, DE, FG, and HI contribute (Carter et al., 2003; Ludmerer et al., 1996 Ludmerer et al., , 1997 Roth et al., 2006; White et al., 1999) .
Up to 72 molecules of the minor capsid protein, L2, are also found in the viral capsid. Similar to PY VP2/3, L2 density was located at the central internal cavity of each capsomere by cryo-EM but the majority of the L2 chain was not discernable (Buck et al., 2008) . The observation that L2 can occupy binding sites in adjacent capsomers raises the possibility of homotypic L2 interactions. Biochemical evidence suggests that L2 residues 396 to 439 (HPV11) mediate the interaction with capsomeres probably via hydrophobic interactions (Finnen et al., 2003) . Another study found L2 residues 129 to 246 and 384 to 460 contained independent L1 interaction domains (BPV1) (Okun et al., 2001 ). An N-terminal region of L2 (residues 60 to 120 of BPV1) has been shown to be surface-exposed although this was not evident in the cryo-EM reconstruction study, possibly due to relative structural disorder (Kondo et al., 2007; Liu et al., 1997) . Additional evidence suggests that the extreme N-terminus folds back into the capsid thus rendering it inaccessible to antibody binding and protease cleavage (Richards et al., 2006; Yang et al., 2003) . Since the central cavity of capsomeres is not large enough to allow the passage of polypeptide chains, it is likely that the L2 N-terminus extends to the capsid surface between neighboring capsomeres, in line with observations that L2 protein stabilizes capsomere interactions under reducing conditions .
Receptors

Polyomaviruses
Polyoma-and papillomaviruses use various forms of carbohydrates as primary attachment receptors. Whereas JCV preferentially utilizes α(2,6)-linked sialic acid attached to the serotonin 5-HT (2A) receptor (Elphick et al., 2004; Komagome et al., 2002) , SV40, BKV, and PyV use gangliosides GM1, GD1b and GT1b, and GD1a and GT1b, respectively (Low et al., 2006; Tsai et al., 2003) . These are all branched compounds which differ in length, composition and linkage of the side chains. BKV can also utilize N-linked glycoproteins with (α2,3)-linked sialic acid (Dugan, Eash, and Atwood, 2005) and SV40 has been shown to bind to major histocompatibility (MHC) class I antigen, but is endocytosed independently (Anderson et al., 1998; Atwood and Norkin, 1989; Breau et al., 1992) . Structural analysis shows that GM1 binds to SV40 VP1 in a shallow groove formed by the BC-, DE-, and HIloops (Neu et al., 2008) . Three VP1 molecules within a capsomere contribute to the binding site and both arms of GM1 make contact with VP1. The α-5-N-acetyl neuraminic acid (NeuNAc) arm interacts with residues from the HI-and BC1-loops of one monomer (Pocket 1). In addition, contacts were observed to the BC2-loop of the clockwise neighbor. The Gal-(β1,3)-GalNAc arm contacts the HI-and BC2-loops as well as the DE-loop of the counterclockwise neighboring VP1 molecule (Pocket 2). Individual binding affinity is rather low with K d ranging between 1 and 5 mM, which is probably offset by the presence of repetitive binding sites (Neu et al., 2008) . It was recently demonstrated that SV40 binds more strongly to a modified GM1 carrying a terminal glycolyl group (Campanero-Rhodes et al., 2007) . The modification is found in simians whereas humans are unable to synthesize this variant GM1. The available structure accommodates the modification and modeling predicts a higher affinity corresponding to the experimental results (Neu et al., 2008) . The structure of PyV with its oligosaccharide receptors GD1a and GT1b is not known. GD1a and GT1b share a terminal (α2,3)-linked sialic acid (NeuNAc)). Instead a Y-shaped hexasaccharide NeuNAc-1-(α2,3)-Gal-(β1,3)-[(α(2,6)-NeuNAc-2]-Glc-NAc-(β1,3)-Gal-(β1,4)-Glc was used for crystallization studies (Stehle and Harrison, 1997; Stehle et al., 1994) . The hexasaccharide shares the NeuNAc-1-(α2,3)-Gal-(β1,3) arm with GD1a and GD1b, which yielded a well ordered structure in all five monomers of the pentamer, whereas the second arm was less ordered. The NeuNAc-1-(α2,3)-Gal-(β1,3) arm contacts residues in the BC and HI loops. GD1b and GT1b, which serve as binding receptors for BKV, share a terminal α2,8-linked NeuNAc, which is thus probably the main contributor to interactions with the VP1 pentamer. No structural information is available for BKV. The interaction of JCV VP1 with NeuNAc-(α2,6)-Gal-(β1,3)-GalNAc was modeled based on structures of other PY viruses and mutational analysis of JCV VP1 and was predicted to involve residues in the BC-, DE-, and HI-loop .
Papillomaviruses
Early work investigating the PV cell surface receptor found that PVs bind to a widely expressed and evolutionarily conserved cell surface receptor and that cell surface interaction depended primarily on L1 Roden et al., 1994; Volpers et al., 1995) . It was later demonstrated by Joyce et al. that PV VLPs have a high binding affinity for glycosaminoglycans (GAGs), especially heparan sulfate (Joyce et al., 1999) . This study showed that HPV11 L1-only VLPs can interact with immobilized heparin and soluble heparin could inhibit binding of VLPs to HaCaT cells. Later work demonstrated that the interaction with cell surface HSPGs is critical for infection with HPV16 and HPV33 pseudovirions of COS-7 cells (Giroglou et al., 2001 ). This study also suggested that, after binding to the HSPG, the capsids shift from a form that is sensitive to competition by exogenous heparin to a form that is resistant, suggestive of an interaction of the virion with a second receptor molecule. Additional experiments have revealed potential differences in the HSPG requirements among HPV types in vitro. HPV31 was reported to not require HSPG interaction for keratinocyte infection, but did interact with COS-7 in an HS-dependent manner (Patterson et al., 2005) . Neither heparin nor carrageenan, another sulfated polysaccharide, was found to inhibit HPV5 infection (Buck et al., 2006) .
Heparan sulfate proteoglycan, HSPGs, are well described receptors for growth factors, lipoproteins and numerous bacteria and viruses (reviewed in Bernfield et al., 1999) . The two major families of cell surface HSPGs are the syndecans and glypicans (reviewed in Bernfield et al., 1992; Fransson, 2003) . HPV16 virus-like particle (VLP) binding and HPV11 infection does not appear to require a specific HSPG protein core for infection (Shafti-Keramat et al., 2003) . Syndecan-1 is the predominant HSPG in epithelial tissue and may serve as the primary attachment receptor in vivo due to its high level of expression in the appropriate target cell and upregulation during wound healing (Bernfield et al., 1992; Elenius et al., 1991; Gallo et al., 1994) .
HSPG contain unbranched oligosaccharides composed of alternating disaccharide units of uronic acid and glucosamine, which are sulfated and acetylated to various degrees. O-sulfation occurs at the 2-O, 3-O, and 6-O position of the uronic acid and at the 3-O and 6-O position of the amino sugar. The amino group of the glucosamine may be either acetylated or sulfated. In vitro studies have shown that infectious entry of PV requires N-as well as O-sulfation. However, only O-sulfation is required for binding suggesting that distinct interactions with HSPG may occur subsequent to cell interaction (Selinka et al., 2003) . This was recently confirmed by the use of heparan sulfate (HS) neutralizing reagents applied post attachment, which efficiently blocked HPV infection without release of virions from the cell surface . The minimal length requirement for HS binding is 8 monosaccharide units (Knappe et al., 2007) . However, it is likely that virion attachment to cells occurs via polyvalent interactions as monovalent binding of HS molecules to virions does not block infection (Bodevin et al., submitted for publication). Primary attachment is mediated by positionally conserved lysine residues (K278, K356, K361 for HPV16) located at the rim of capsomeres. Modeling suggests that several L1 monomers of a capsomere contribute to a single receptor binding site, five of which are present per capsomere (Knappe et al., 2007) . In this study, an exchange of lysine residue 443, which is located at the vertex of capsomeres, did not significantly affect cell and HS binding but strongly impaired infectivity of mutant virions, suggesting that secondary binding events involve residues found in the cleft between capsomeres. However, another study found that a neutralizing monoclonal antibody that binds to an epitope in this intercapsomeric cleft prevented cell surface association and consequently infection (Day et al., 2007) .
In vitro studies have shown that PV also bind to components of the extracellular matrix (ECM) secreted by keratinocytes and can be transferred from ECM to cells in an infectious manner (Fig. 2) . Laminin 5 (LN5) as well as HS moieties are able to mediate binding to the ECM (Culp et al., 2006a (Culp et al., , 2006b Selinka et al., 2007) . However, infectious transfer from the ECM seems to require HS binding , even though affinity of virions is higher to LN5 than to HS (Culp et al., 2006b) . Importantly, infection can occur in the absence of ECM binding, as evidenced by the permissiveness to HPV infection of cell lines that secrete ECM lacking LN5, like e.g. COS-7 cells. The ECM might function as the in vitro equivalent of the epithelial basement membrane, which was recently identified as the primary site of virus binding during genital tract infection in vivo (Roberts et al., 2007) . Studies using this murine cervicovaginal challenge model suggest that virions bind initially to the basement membrane prior to transfer to the basal keratinocyte cell surface. It has been possible to utilize this model to investigate the HSPG dependency of HPV16, HPV31 and HPV5 infection in vivo (Johnson et al., 2009) . Through an examination of both binding and infection of pseudovirions after heparinase treatment it was found that HSPGs are the primary attachment factors for all three of these virus types in vivo. However, HPV5 differed from HPV16 and HPV31 in that infection could not be significantly prevented with heparin treatment despite having a demonstrable interaction. The most likely explanation for this discrepancy is that HPV5 has several distinct heparan sulfate binding sites, and that a site that does not efficiently interact with soluble heparin mediates cell surface attachment.
Accumulating evidence suggests that a secondary receptor is involved in infectious internalization of PV particles subsequent to HSPG interaction Selinka et al., 2007) . A recent study demonstrates that induction of a conformational change by precleavage of L2 within capsids with furin, further described below, allows binding and infection in the absence of cell surface HSPG . The identity of this second binding moiety is still Fig. 2 . Model of ECM and cell surface events following HPV16 infection. (1) HPV16 virions bind to primary attachment receptors, HSPG1, on ECM (basement membrane in vivo) or the cell surface. Capsids have also been shown to bind to ECM-resident laminin 5, however, this interaction seems to be of lesser importance for productive infection. (2) Capsids are transferred to secondary HSPG binding sites present on the cell surface (HSPG2). Whether transfer from primary ECM binding sites to primary cell surface binding sites occur has not been directly investigated. Interaction with the HSPG2 cell surface receptor induces conformational changes resulting in the exposure of the L2 amino terminus and subsequent furin cleavage at a conserved cleavage site. Host cell cyclophilin B facilitates the conformation changes. (3) These events seem to induce an additional conformational change that either reduces the affinity of capsids to HSPG or result in exposure of sites required for handover to a putative non-HSPG uptake receptor, which then triggers endocytosis. L1 likely provides the binding site for the uptake receptor. Noninfectious internalization is observed in presence of furin and cyclophilin inhibitors.
unknown. α 6 -integrin partnered with either β 1 -or β 4 -integrin has been suggested as secondary receptor (Culp et al., 2006b; Evander et al., 1997; McMillan et al., 1999) but its involvement in HPV infection is controversial and awaits further confirmation (Giroglou et al., 2001; Shafti-Keramat et al., 2003; Sibbet et al., 2000) . As mentioned previously, the cell surface interactions are predominantly L1-dependent, although, possibly the L2 protein may contribute to surface interactions. One of the regions of L2 that has been described to mediate this appears not to be displayed on the virion surface in solution. Because this region, residues 13 to 31 of HPV16 L2, is not necessary for virion binding, it was proposed to interact with a cell surface molecule after the virion has attached to a primary receptor (Yang et al., 2003) . This interpretation suggests that there is a conformational change in the viral particle at the cell surface that unmasks this domain of L2.
Attachment-induced conformational changes of capsid proteins
Polyomaviruses
Many viruses undergo conformational changes following cell attachment to trigger downstream events including membrane fusion, secondary receptor interactions and uncoating. Post-attachment conformational changes have also been observed for both polyoma-and papillomaviruses. One report suggested that PyV capsids undergo conformational changes following interaction with its oligosaccharide receptor (Cavaldesi et al., 2004) , even though these changes were not discernible in X-ray structures of capsids in association with their carbohydrate receptors Harrison, 1996, 1997; Stehle et al., 1994) . Cavaldesi showed that preincubation with NeuNAc or NeuNGc increases cell binding and infectivity and changes the protease sensitivity of capsid proteins. Similar changes were observed after cell attachment. The exact nature of these conformational rearrangements is unknown.
Papillomaviruses
For PVs, a conformational change is reflected in the described shift from a heparin-sensitive to heparin-resistant form (Giroglou et al., 2001) . Supporting this are additional data from the same group which describe the improved recognition of a neutralizing L1 epitope after virion attachment to the cell surface (Selinka et al., 2003) . Consistent with this idea, L2 can induce cross-type neutralizing antibodies as a free protein immunogen, but not when it is found in its typical context, assembled in a PV capsid (Roden et al., 2000) . This was mechanistically explained by a later paper that showed L2 could be cleaved by furin on the cell surface. This cleavage resulted in the accessibility of the L2 cross-neutralization epitope . Therefore, L2-dependent neutralization must occur following these events and not in solution. Furin cleaves the L2 protein at a consensus cleavage site that is conserved among all papillomaviruses (Richards et al., 2006) . Proteolytic cleavage is essential for successful infection and cannot be substituted by incorporation into virions of an Nterminally truncated form of L2. This suggests that the N-terminus is essential for L2 protein to adopt a correct conformation within the assembled capsid.
It was also found that capsid interaction with HSPG results in a conformational change that results in the exposure of the amino terminal furin cleavage site. Following furin cleavage an additional conformational change apparently exposes the binding site for the secondary cell surface receptor, or it lowers the affinity for the primary receptor which results in the hand-off to the second receptor. It is likely that this unidentified receptor is L1-specific, because trafficking of L1 VLPs, as examined by immunofluorescence, is indistinguishable from that of infectious virions through this stage . Additionally, L1/L2 capsids are internalized normally under conditions of furin inhibition (Richards et al., 2006) . However, it is possible that subtly disparate pathways could appear microscopically similar.
Recent unpublished observations indicate that cell surface-associated cyclophilin B (CyPB), a cellular petidyl-prolyl cis/trans isomerase, may catalyze exposure of the furin cleavage site on the cell surface. Inhibition of CyPB does not result in release of virions from cells but induces their noninfectious internalization, suggesting that it acts prior to or mediates the capsid protein rearrangements which eventually result in reduced affinity of virions to HS and the subsequent transfer to the non-HSPG receptor (M. Bienkowska-Haba, H. Patel, and M.S., manuscript submitted). Other reports have found that inhibition of furin cleavage results in non-productive entry, but inhibition of the conformational change allowing exposure of the furin cleavage site results in retention of the virus on the cell surface (Day et al., 2007 . This is apparently the mechanism employed by the dominant class of L1-specific neutralizing antibodies.
Taken together, these recent advances in our understanding of early events of HPV infection suggest a dynamic model of virion-cell surface interactions which has probably evolved to ensure the inacessibility of critical regions. The remarkable conservation of the requirement for L2 furin cleavage is suggestive that this elaborate process evolved early in the speciation of papillomaviruses to prevent a host antibody response to conserved virion epitopes that are essential for infection. These sequences are inaccessible at the surface of intact virions, but become more exposed by HSPG and cyclophilin B interaction, and furin cleavage as detailed above.
Endocytosis
Polyomaviruses
Receptor usage determines the endocytic pathway taken by polyomaviruses. As gangliosides accumulate in caveolae, SV40, PyV or BKV enter cells via caveolar endocytosis Gilbert and Benjamin, 2004; Kartenbeck et al., 1989; Pelkmans et al., 2001 ). In the case of SV40, this is associated with transient actin stress fiber break down followed by renewed recruitment of actin to form actin tails. Transient dynamin II recruitment and tyrosine kinase mediated phosphorylation of caveolae-resident proteins accompanies this process and are required for formation of caveolae and consequently successful infection (Pelkmans et al., 2001 ). Inhibition of tyrosine kinases blocks SV40 entry at the mouths of caveolae (Fig. 3) . BKV also requires actin filament reorganization as the inhibitor jasplakinolide interferes with successful infection . In contrast, JCV which utilizes serotonin receptors for binding is internalized by clathrin-dependent endocytosis (Pho et al., 2000) . JCV also induces tyrosine kinase-mediated signaling, which is required for virus entry . However, unlike SV40 (Dangoria et al., 1996) it additionally activates mitogen-activated protein kinases ERK1 and ERK2 .
Papillomaviruses
Neutralization experiments with cultured cells demonstrated an extended period of susceptibility of infectious PV capsids to the addition of neutralizing antibodies (Christensen et al., 1995; Culp and Christensen, 2004) . Other studies have demonstrated heparin neutralization of HPV pseudovirus infection several hours following virion addition (Giroglou et al., 2001; Smith et al., 2007) . These data indicate an unusually protracted residence on the cell surface for PVs. The reason for the delayed kinetics observed for PVs is undetermined. Possibly the conformational changes described previously are slow events. Alternatively, the secondary receptor could be sparsely arrayed or exhibit particular requirements for endocytosis.
In vitro experiments show that following association with a cellular receptor, this receptor must bind to F-actin in order to be pulled by actin retrograde flow towards the cell body (Schelhaas et al., 2008) . This requirement may contribute to prolonged residence on the cell surface. Additionally, infection seems to be highly asynchronous as highly sensitive nested RT-PCR techniques detected early viral transcripts as early as 2 h post-binding for BPV-4 (Sibbet et al., 2000) , 4 h for HPV31 (Patterson et al., 2005) and 12 h for BPV-1 . Since more quantitative techniques show a gradual increase in the number of viral transcripts in the 2-4 days following infection in most susceptible cell lines (Culp and Christensen, 2004 ), it appears that the intracellular events leading to a virus establishment are also proceeding slowly.
The mechanisms by which PVs are endocytosed are still unclear and these studies have yielded little concordance. An early study that analyzed BPV1 entry concluded that this virus utilizes a clathrindependent endocytic pathway for infectious uptake, albeit with atypical kinetics . This study utilized a combination of microscopic analyses and biochemical inhibition of described pathways. Colocalization of particles was found with AP-2, a clathrin adaptor molecule, transferrin receptor, which traffics through the early endosomes and lamp 2, a late endosomal/lysosomal marker. Inhibitors which blocked infection included chlorpromazine, bafilomycin A, latrunculin B, nocodozole and ammonium chloride. Clathrindependent endocytosis of BPV1 was recently confirmed using pseudovirions based on the sensitivity to chlorpromazine and initial colocalization of virions with the early endosomal antigen (EEA-1) (Laniosz et al., 2008) . Chlorpromazine sensitivity was also reported for HPV16 pseudovirions . Selinka et al. examined a set of biochemical inhibitors for effects on HPV-33 pseudovirus infection and found a dependence upon an intact actin cytoskeleton and microtubules (Selinka et al., 2002) . In contrast to these studies, Spoden et al. observed clathrin-and caveolae-independent internalization of HPV16 pseudovirions in HeLa and HEK 293TT cells. Entry occurred by a mechanism that was resistant to combined siRNA-mediated down regulation of caveolin-1 and clathrin heavy chain as well as resistant to over-expression of dominant negative mutants of caveolin-1 and eps-15 (EGF receptor pathway substrate clone No. 15, which plays a role in clathrin coated vesicle formation) (Spoden et al., 2008) . These authors suggested that tetraspanin-enriched microdomains serve as platforms for internalization by an uncharacterized internalization pathway. None of these studies could demonstrate an effect of caveolae disruption on infection, via nystatin or filipin treatment on HPV16 infection.
An early study utilizing infectious VLP-DNA complexes found unexpectedly that HPV-31 transduction, but not transduction by VLPs of several other HPV types, was inhibited by nystatin, a caveolae inhibitor (Bousarghin et al., 2003) . This result was confirmed and expanded upon by the Ozbun group. They described the caveolar uptake of HPV31 virions in keratinocytes . However, one study found that biochemical inhibition of clathrindependent uptake did prevent HPV31 infection (Hindmarsh and Laimins, 2007) . As previously mentioned HPV31 appears to interact with HSPG similarly to HPV16 for in vivo infection. Possibly HPV31 interacts differently with or has a unique co-receptor that shunts it into a different internalization pathway. There is precedence for closely related naked icosahedral viruses using distinct uptake pathways, as noted for polyomaviruses.
Intracellular trafficking and uncoating
Polyomaviruses
In general the complexities of vesicular trafficking are still not well understood, and the various mechanisms by which viruses exploit this system are even more unclear. There are a number of instances in which viral trafficking does not conform to the established kinetics of known endocytic pathways. In addition, an increasing number of reports describe a "cross-talk" amongst the diverse internalization pathways (Pelkmans et al., 2004) . As more dominant-negative versions and validated siRNAs become available for genes involved in intracellular membrane trafficking, the dependence upon biochemical inhibition is lessened and this may allow for more specific interference of the various pathways. Fig. 3 . Endocytosis of polyomaviruses. SV40 and BK viruses which apparently utilize the same endocytic route are indicated in green. They are endocytosed, possibly via transfer from lipid rafts, into caveolae. Caveolar + pinocytic vesicles deliver the virions into the caveosome. They are then transported into the endoplasmic reticulum via caveolin-free, COP1+ vesicles. Murine polyomavirus, indicated in blue, can be transported from lipid rafts into caveolin-positive monocytic vesicles. These vesicles fuse with early endosomes and the virus is then transported into caveosomes and subsequently into the ER. Direct fusion of monocytic vesicles with the ER has also been demonstrated to deliver PyV virions. JC virus, indicated in red, is internalized in clathrin coated vesicles (CCV) and transported through early endosomes en route to the caveosome. It is then delivered into the ER via a route similar to SV40 and BK.
Once caveolin-1 containing endocytic vesicles have budded from caveolae, SV40 virions accumulate in peripheral organelles, named caveosomes, which do not contain markers for endosomes, lysosomes, ER or Golgi (Pelkmans et al., 2001) . Caveosomes were first discovered using SV40 but are preexisting, intracellular, non-acidic organelles to which caveolin-containing but not clathrin-coated endocytic vesicles are targeted. From here SV40 is sorted into tubular caveolin-free vesicles (Pelkmans et al., 2001) , which are transported in a microtubule-dependent manner to the endoplasmic reticulum (ER) via an intermediate compartment that contains β-COP and is sensitive to brefeldin A (Norkin et al., 2002; Richards et al., 2002) . These data suggest that COPI vesicles mediate the retrograde transport of SV40 from caveosomes to the ER. As lipid binding sites for SV40 are present in rough ER membranes it seems likely that the virus is bound to its ganglioside receptor throughout the transfer from the plasma membrane to the ER (Tsai et al., 2003) . BKV has also been suggested to traffic through the ER similar to SV40 (Gilbert and Benjamin, 2004; Gilbert et al., 2003; Low et al., 2006; Tsai et al., 2003) . In contrast, caveolae-derived pinocytic vesicles containing PyV were shown to fuse with the early endosomes. Virus was then delivered into the caveosome with subsequent delivery into the ER. However, in the absence of functional caveolae PyV can be internalized via a noncaveolae, non-clathrin pathway that also targets the ER suggesting a cross-talk between clathrin-and caveolae-dependent endocytosis (Liebl et al., 2006) . A cross-talk between these internalization pathways has also been reported for JCV (Querbes et al., 2006) . After clathrin-and eps15-dependent endocytosis and transport to early endosomes , JCV is sorted to caveosomes in a Rab5-GTPase-, cholesterol-, caveolin-1-, and pH-dependent manner. Similar to SV40, JCV is further transported from caveosomes to ER via a brefeldin A-sensitive pathway suggesting the involvement of ARF1 GTPase and COPI vesicles (Querbes et al., 2006) .
After endocytic uptake, access of most ligands to the cytosol is limited and tightly regulated. Nonenveloped viruses either lyse the limiting vesicular membrane or generate a pore through it, which requires conformational change of the capsid or uncoating to expose hydrophobic domains. Uncoating of SV40 is first observed in the ER by immunofluorescent detection of minor capsid proteins VP2 and VP3, which are inaccessible to antibody binding in intact virions (Norkin et al., 2002) . Several ER-resident proteins are required for virion disassembly and transport of the viral genome across the ER membrane into the cytosol. It is unclear at present if the membrane is crossed by partially disassembled virions or if only the genome is translocated into the cytoplasm or even directly into the nucleus thus bypassing nuclear pores. It seems clear, however, that different polyomaviruses may have evolved different mechanisms to escape the ER.
SV40 requires the activity of two thiol-disulfide oxidoreductases, ERp57 and PDI, to complete infection. ERp57 converts C9-C9 intrachain disulfide bonds to C9-C104 interchain disulfides (Schelhaas et al., 2007) . This requires a reduced C104 residue in close contact to the C9-C9 disulfide bond that is likely only available at the three-fold axis linking pentavalent with hexavalent capsomeres . Isomerization results in the uncoupling of twelve of the 72 pentamers, which are released from the virion at low Ca
2+
. It seems likely that the pentavalently organized pentamers are affected and that it requires the low Ca 2+ environment of the cytosol (Schelhaas et al., 2007) . ERp57 is not essential for infection of C9-C104 mutant viruses confirming that it isomerizes disulfide bonds formed by these two cysteine residues. In addition to ERp57 and PDI, Derlin-1 and Sel1L, members of the ER-associated degradation (ERAD) pathway, are essential for completion of SV40 infection. It was therefore suggested that SV40 virions that have undergone disulfide isomerization utilize the translocation machinery used for misfolded ER components to escape from the ER into the cytosol. It seems likely that in addition to these cellular factors, VP2/VP3 contribute to ER escape. Both have been shown to associate with and destabilize membranes. This propensity of VP2/VP3 seems to be regulated by interaction with VP1 (Daniels et al., 2006a (Daniels et al., , 2006b . Another component of the ERAD pathway, Derlin-2, has been shown to be essential for PyV infection. Similar to ERAD components essential for SV40 infection, its activity is required in the ER. Derlin-2 can be bypassed by introducing viral DNA into the cytosol, suggesting that it mediates the passage of virions across the ER membrane (Lilley et al., 2006) . Similar to SV40, PyV VP2/VP3 associate with cellular membranes (Delos et al., 1993) . Exposure of the minor capsid proteins is catalyzed by the ER-resident chaperone ERp29 (Magnuson et al., 2005) . ERp29 induces a conformational change in PyV particles affecting the C-terminus of VP1 without inducing complete disintegration of the virion structure. The change results in the association of virions with ER membranes. Portions of VP2 are exposed, which mediate binding to ER membranes. VP2 then integrates into and perforates model membranes. Although VP3 can also bind and integrate into membranes it cannot perforate them (Rainey-Barger et al., 2007) . PyV may not require disulfide isomerization of VP1 as it is not extensively disulfide cross-linked (Schelhaas et al., 2007) .
Papillomaviruses
Given the divergent reports regarding the endocytic mechanisms utilized by PV, it is unsurprising that the subject of intracellular trafficking of PV-containing vesicles and the cellular compartments involved is also highly controversial. There is near consensus that successful infection requires acidification of endocytic vesicles suggesting that PV particles must pass through the endosomal compartment Selinka et al., 2002; Smith et al., 2008; Spoden et al., 2008) . Colocalization with early endosome markers has been observed for BPV1 (Day, Lowy, and Schiller, 2003; Laniosz et al., 2008) , but not for HPV16 pseudovirions (Spoden et al., 2008) . HPV31 particles were found to enter via caveolae, be transported to caveosomes, and then to early endosomes in a Rab5 GTPase-and pH-dependent manner (Smith et al., 2008) . Since the infection did not require functional Rab7, it was suggested that infectious genomes exit the endocytic pathway prior to transit into the late endosomes. In contrast, the Meneses lab reported initial entry of BPV1 via a clathrin-dependent pathway and subsequent delivery from the early endosome into the caveosome with later entry into the ER. Over-expression of a caveolin-1 dominant-negative protein prevented infection without affecting the initial internalization (Laniosz et al., 2008) . However, other work has shown that the BPV1 genome accumulates in late endosomes or lysosomes if egress from the endocytic compartment to the cytosol is blocked (Kämper et al., 2006) .
The advent of siRNA-mediated gene knockdown and dominantnegative constructs targeting multiple endocytic mediators has allowed more scrutiny of the PV uptake pathways. Unfortunately at this juncture there is no concordance on any issue. The studies are complicated by the fact that different laboratories are utilizing different virus sources. In early studies pseudovirions were used prior to the appreciation of virion maturation. Immature viruses may enter by different mechanisms or would at least exhibit an altered conformation. Different cell lines have also been examined. It is reasonable to assume that cultured cell lines from disparate lineages have different "dominant" endocytic pathways. Therefore, the same cargo could utilize a different route. Another issue is that inhibition of these pathways is usually evaluated by observing the entry of small, physiological cargoes, i.e. transferrin, whereas in the experimental conditions we are evaluating the entry of a large, multivalent virus. Another problem is that inhibition of one endocytic pathway often results in a compensatory upregulation of a different pathway. This cellular effect can obfuscate the interpretation if the virus can utilize two different modes of entry, as has been shown for SV40 (Damm et al., 2005) . It has long been accepted that SV40 enters via caveolae.
However, this study showed that SV40 can productively enter and infect caveolin-deficient cells. There has also been a newfound appreciation for the interaction between entry pathways that were formerly considered to function separately. It is likely that further experimentation will result in more understanding of PV entry and might lead to the discovery of entirely new entry pathways altogether. At this point a comprehensive study of intracellular trafficking by different PV types in parallel in normal keratinocytes is still lacking. Of most interest would be the development of a system for evaluation of selective in vivo inhibition of the various pathways. However that would pose a new set of technical hurdles. Two assays have been described to examine the uncoating of papillomaviral pseudoviruses. They were developed in tandem to detect exposure of either an interior region of L2 or the BrdU-labeled viral pseudogenome (Day et al., 2004) . Examination of when these determinants became accessible to antibody staining suggested that uncoating occurs in endocytic vesicles prior to transfer to the cytosol. That disassembly of the viral particle must occur before nuclear import was suggested by previous reports showing that intact HPV capsids exceed the size capacity for transit across the central NPC channel (Merle et al., 1999; Nelson et al., 2000) .
It has been shown that the minor capsid protein, L2, allows escape of the viral genome from the endosome (Kämper et al., 2006) . L2 was found not to be required for viral uncoating but was necessary for egress from the endocytic pathway. A short, hydrophobic peptide derived from the carboxyl terminus of HPV-33 L2 harbors membrane disrupting capacity. If this region is deleted the resultant pseudovirus is unable to establish infection, despite unaffected DNA encapsidation and cell surface interactions. Microscopic analysis of non-infectious capsids containing a similar deletion in BPV-1 L2 shows that the mutant L2 protein and the viral genome are retained together within the endosomal compartment at late timepoints post-infection.
The issue of how the papillomaviral genome transits from the endosome to the nucleus has not been systematically addressed. Although furin cleavage of L2 occurs at the cell surface we believe that the functional effect is later in entry. Furin cleavage of L2 could enable the release of the L2-genome complex from L1, because L1 does not appear to exit from the endosomal compartment. Another possibility is that it could promote L2 binding to a specific receptor. It is intriguing that a binding site for syntaxin-18 was mapped to a peptide immediately downstream of the cleavage site. It was found to bind to L2 residues 40 to 44 of BPV1 and a syntaxin-18 dominant negative blocked infection (Bossis et al., 2005; Laniosz et al., 2007) . However, the mechanism or consequence of this interaction has not yet been fully elucidated. Syntaxin 18 is an ER-resident protein. To date there has been no convincing ER localization of PV during infectious entry. Other data support co-delivery of L2 and genome to the nucleus for HPV16 and BPV1 L2, perhaps in conjunction with a cell-encoded chaperone .
The microtubule disrupting drug nocodazole inhibits PV infection at a late step in infection Selinka et al., 2002) . It is well established that vesicle trafficking occurs along microtubules. However, microtubule-dependent transport may also be required for the post-endosomal step of delivering the viral genome into the nucleus. Cytoplasmic transport along microtubules is mediated by motor protein complexes that use cellular energy to move cargo. The L2 protein of HPV16 and HPV33 was found to interact with the microtubule network via the motor protein dynein during infectious entry . The C terminal 40 amino acids of L2 were found to be essential for interaction with the dynein complex.
It was shown that L2 and the viral genome colocalized in the nucleus at ND10 domains (PML nuclear bodies) (Day et al., 2004) following infection suggesting that they are translocated to the nucleus as complex. Cytoplasmic microinjection of L2-specific antibodies blocks infection confirming their continued association in the cytosol (M. Bienkowska-Haba, L. Hilbig, and M.S., unpublished observations).
Whether nuclear translocation is mediated by nuclear localization signals provided by L2 as previously suggested (Bordeaux et al., 2006; Fay et al., 2004) or by other means awaits further investigations. L1 protein is not detectable in the nucleus, which may be due to its complete shedding during uncoating as it has been shown to accumulate in Lamp/CD63-positive vesicles, which could be late endosomes or multivesicular bodies (Spoden et al., 2008) . The localization of the genome and L2 at ND10 is critical for the establishment of infection in that efficient early PV transcription required either intact ND10 or expression of the PML protein (Day et al., 2004) .
Summary
The tasks of a successful virus include finding and recognizing a suitable cell in which it can replicate. This necessitates receptor engagement, endocytosis, release of the genome, generation of new viral components, and assembly and release of progeny virions. This review has focused on the structure of the newly assembled particles and the early steps in their transmission to the host cell. Polyoma-and papillomaviruses have evolved different mechanisms for delivery of their DNA, but there must be relatedness to the structures which accomplish this as the overall similarity of their capsids is a reflection of the fundamental processes following. The stable virion must necessarily become unstable upon interaction with the host cell leading to eventual release of the genome in the correct cellular environment that ensures expression of its genome. The relationship between the structure and these processes cannot be overlooked. Understanding the mechanisms by which the virion achieves controlled lability may clear the path to better understanding of the concurrent endocytic events. Appreciation of the host cell that is the vessel for these processes is also critical. Utilization of cells across lineages and transformation states may yield disparate results. Biochemical and genetic inhibitors, although necessary tools for these studies, must be employed with the perception of the resultant cellular effects. With these cautions we anticipate exciting strides to be made in these fields.
